Clinical Trials on Cerebral Small Vessel Disease in Netherlands

Total 524 results

Ludwig-Maximilians - University of Munich
Maastricht University Medical Center; UMC Utrecht; University of Oxford; University...

Terminated

Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function (TREAT-SVDs)

Cerebral Small Vessel Diseases

Netherlands, Germany, United Kingdom
Radboud University Medical Center

Recruiting

Hyperintense: Midlife Hypertension and the Brain

Hypertension | Small Vessel Cerebrovascular Disease

Netherlands
Maastricht University Medical Center

Completed

Blood-brain Barrier Quantification in Cerebral Small Vessel Disease

Cerebral Hemorrhage | Cerebral Small Vessel Disease | Blood-Brain Barrier Permeability | Cortical Stroke

Netherlands
University of Cambridge
Radboud University Medical Center; Wolfson Brain Imaging Centre

Recruiting

INflammation and Small Vessel Disease Study (INSVD)

Stroke | Inflammation | Cerebral Small Vessel Diseases

Netherlands, United Kingdom
Leiden University Medical Center
Alzheimer Nederland

Recruiting

WHIte MAtter Hyperintensity Shape and Glymphatics (WHIMAS)

Cognitive Impairment | Mild Cognitive Impairment | Cerebral Small Vessel Diseases | Dementia, Vascular | Cognitive Decline | Dementia, Mixed

Netherlands
The George Institute
University of Sydney

Terminated

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study (TRIDENT COG)

Hypertension | Cerebral Small Vessel Diseases | Dementia, Vascular | Stroke Hemorrhagic | Cognitive Decline | Intracerebral Hemorrhage

Australia, Netherlands
Leiden University Medical Center

Recruiting

Antibiotics Against Amyloid Angiopathy (BATMAN)

Cerebral Amyloid Angiopathy

Netherlands
Leiden University Medical Center

Recruiting

Coach Pilot Study: Assessing Cognitive Function and Related Small Vessel Disease Markers After Intracerebral Hemorrhage (COACH)

Cognitive Decline | Cerebral Amyloid Angiopathy | Intracerebral Hemorrhage | Hypertensive Hemorrhage, Intracranial

Netherlands
Pfizer

Completed

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

Cerebral Amyloid Angiopathy

Canada, United States, Netherlands, France, United Kingdom
University Medical Center Groningen

Unknown

Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)

Vasculitis | Wegener's Granulomatosis

Netherlands
Amicus Therapeutics

Completed

A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers

Fabry Disease

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Fabry Exercise Intolerance Study (FEISTY)

Fabry Disease | Fabry Disease, Cardiac Variant

Netherlands
Johns Hopkins University
Boston University; Mayo Clinic; University of Alabama at Birmingham; University... and other collaborators

Terminated

Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study (RAVELOS)

Microscopic Polyangiitis | Granulomatosis With Polyangiitis

United States, Netherlands
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; Immune Tolerance Network (ITN)

Completed

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis (RAVE)

Vasculitis | Wegener's Granulomatosis | Microscopic Polyangiitis

United States, Netherlands
Khondrion BV
Julius Clinical

Completed

The KHENERGYZE Study

Mitochondrial Diseases | Mitochondrial Myopathies | MELAS Syndrome | Mitochondrial Encephalomyopathies | MIDD

Netherlands, Denmark, Germany, United Kingdom
Protalix
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy of PRX-102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agalsidase Alfa)

Fabry Disease

Australia, Netherlands, United Kingdom, Canada, Czechia, Norway, Slovenia
Amicus Therapeutics

Completed

Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease

Fabry Disease

Canada, Belgium, United States, Australia, Netherlands
Maastricht University Medical Center
Neuroplast; NovaSignal Corp.; Glycocheck

Recruiting

Micro- and Macrovascular Parameters in Delayed Cerebral Ischemia (PDMMS)

Delayed Cerebral Ischemia | Aneurysmal Subarachnoid Hemorrhage

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine (ISCHEMIA)

Delayed Cerebral Ischemia | Aneurysmal Subarachnoid Hemorrhage

Netherlands
Maastricht Radiation Oncology
Maastricht University Medical Center

Terminated

Positron Emission Tomography-Computed Tomography (PET-CT) High-grade Glioma

Cerebral Astrocytoma, High Grade

Netherlands
Genzyme, a Sanofi Company

Completed

A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms (FIELD)

Fabry Disease

United States, Poland, Netherlands, Canada, Argentina, United Kingdom, Norway, Brazil, Czech Republic
Maastricht University Medical Center
The International Nut and Dried Fruit Council (INC)

Completed

Mixed Nuts and Brain Vascular Function

Cerebral Blood Flow | Brain Vascular Function

Netherlands
Amsterdam UMC, location VUmc
University Ghent; Reade Rheumatology Research Institute

Recruiting

Effect of Functional Power Training on Calf Muscle Length and Strength in Children With Spastic Paresis (MegaMuscle)

Cerebral Palsy, Spastic

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Cerebral Hemodynamics During Sustained Intra-operative Hypotension

Cerebral Autoregulation

Netherlands
UMC Utrecht
Netherlands Organisation for Scientific Research

Terminated

Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility Study

Subarachnoid Hemorrhage | Cerebral Ischemia

Netherlands
Catharina Ziekenhuis Eindhoven
Maastricht University

Not yet recruiting

The Contractile Response of the Thoracic Aorta to Vasoactive Substances (AorticContract)

Human Thoracic Aorta Contractility

Netherlands
InflaRx GmbH

Completed

Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis. (IXchange)

Granulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)

Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
Genzyme, a Sanofi Company

Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Fabry Disease

United States, France, Netherlands, Puerto Rico, United Kingdom
Maastricht Radiation Oncology

Completed

Concurrent Chemo-radiation Form NSCLC to a Individualized MLD (BRONC CONC MLD)

Non-small Cell Lung Cancer

Netherlands
UMC Utrecht

Unknown

MRI Optimization Study in Stage III NSCLC

Stage III Non-small Cell Lung Cancer

Netherlands
Maastricht University Medical Center
VieCuri Medical Centre; Stichting de Weijerhorst

Completed

18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Atherosclerosis | Coronary Stenosis | Multi Vessel Coronary Artery Disease | Heart Attack

Netherlands
Radboud University Medical Center
Biotronik AG; Volcano Europe BVBA/SPRL; Stichting Life Sciences & Health; Duke...

Active, not recruiting

iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction (iMODERN)

Acute Myocardial Infarction | Multi Vessel Coronary Artery Disease

Netherlands
Radboud University Medical Center
AstraZeneca

Completed

Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer (Donan)

Non-small Cell Lung Cancer

Netherlands
Radboud University Medical Center
Merck KGaA, Darmstadt, Germany

Completed

PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE) (PINNACLE)

Non Small Cell Lung Cancer

Netherlands
Idorsia Pharmaceuticals Ltd.

Active, not recruiting

A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease

Fabry Disease

United States, United Kingdom, Norway, Germany, Australia, Canada, Spain, Switzerland, Austria, Belgium, France, Netherlands, Poland
Maastricht Radiation Oncology
University of Pennsylvania

Completed

State of the Art Photon Therapy Versus Particle Therapy for Small Lung Tumors; a Planning Study Based on a Reference Dataset of Patients (Lung stage I)

Non Small Cell Lung Cancer

Netherlands
Amsterdam UMC, location VUmc
Boehringer Ingelheim

Recruiting

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer (SHARP)

Advanced Stage Non-small Cell Lung Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. (N12HYB)

Inoperable Locally Advanced Non Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Usefulness of Blood Biomarkers for Overall Survival in NSCLC

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Radiotherapy for NSCLC to a Individualized MLD (BRONC MLD)

Non-small Cell Lung Cancer

Netherlands
Radboud University Medical Center

Terminated

Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy (IDEAL-VMAT)

Stage III Non-small Cell Lung Cancer | Individualized Radiation Dose Escalation

Netherlands
Maastricht Radiation Oncology
Pfizer

Completed

Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC

Non Small Cell Lung Carcinoma

Netherlands
Maastricht Radiation Oncology

Completed

HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy

Non-Small-Cell Lung Carcinoma

Netherlands
Erasmus Medical Center

Recruiting

ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI) (START-TKI)

Non Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase Inhibitor

Netherlands
University Medical Center Groningen

Recruiting

Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer (VULCAN)

Non Small Cell Lung Cancer Metastatic

Netherlands
Maastricht Radiation Oncology

Withdrawn

DE-CT in Lung Cancer Proton Therapy (DE-CT)

Non Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.

Non-Small-Cell Lung Carcinoma

Netherlands
Bayer

Completed

A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

Healthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 Mutation

Netherlands
Maastricht Radiation Oncology
Anticancer Fund, Belgium; Reliable Cancer Therapies

Terminated

Nitroglycerin in Non-small Cell Lung Cancer (Nitroglycerin)

Non Small Cell Lung Cancer (NSCLC)

Netherlands
Hoffmann-La Roche

Completed

An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer

Netherlands

Clinical Trials on Cerebral Small Vessel Disease in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations